Short-Term Outcome of Ischemic Stroke Patients With Systemic Malignancy
- 1 February 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 50 (2) , 507-511
Abstract
Background and Purpose—: Recent guidelines have suggested the potential benefit of intravenous thrombolysis in stroke patients with systemic malignancy who have a reasonable life expectancy of >6 months. However, it is difficult to determine which patients with cancer will have a life expectancy of >6 months. Therefore, we identified the factors associated with 6-month mortality in patients with acute ischemic stroke and systemic malignancy. Methods—: Consecutive stroke patients with systemic malignancy were retrospectively analyzed. We classified the patients into 3 groups: the nonactive cancer, active nonmetastatic cancer, and metastatic cancer groups. We compared the baseline characteristics and 6-month survival rates. Results—: Of the 468 ischemic stroke patients with systemic malignancy during an 8-year period, 223 patients had nonactive cancer, 105 patients had active nonmetastatic cancer, and 140 patients had metastasis. During the 6-month follow-up, 122 patients (26.1%) died (nonactive cancer group [7.2%, 16/223], active nonmetastatic cancer group [11.4%, 12/105], and metastatic cancer group [67.1%, 94/140]). Multivariate Cox regression analysis revealed that the presence of metastasis (hazard ratio, 4.527; 95% CI, 2.175–9.422) was independently associated with 6-month mortality. However, the active nonmetastatic cancer group exhibited similar 6-month mortality to the nonactive cancer group (hazard ratio, 0.711; 95% CI, 0.282–1.795). Gastric/esophageal cancer and pancreatic cancer were also independently associated with 6-month mortality (hazard ratio, 2.068 and 2.389, respectively). Conclusions—: In stroke patients with active cancer, the presence of metastasis and the cancer type were crucial factors associated with 6-month mortality.Keywords
This publication has 9 references indexed in Scilit:
- 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke AssociationStroke, 2018
- Poor long-term outcomes in stroke patients with asymptomatic coronary artery disease in heart CTAtherosclerosis, 2017
- Hypercoagulability and Mortality of Patients with Stroke and Active Cancer: The OASIS-CANCER StudyJournal of Stroke, 2017
- Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic StrokeStroke, 2016
- Poor short-term outcome in patients with ischaemic stroke and active cancerJournal of Neurology, 2015
- Association between incident cancer and subsequent strokeAnnals of Neurology, 2014
- Ischemic Stroke in Patients with Cancer: Is it Different from Usual Strokes?International Journal of Stroke, 2013
- Stroke in patients with cancerNeurology, 2004
- Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with CancerNew England Journal of Medicine, 2003